Cargando…

Immunotherapy of prostate cancer using novel synthetic DNA vaccines targeting multiple tumor antigens

Prostate cancer is a prevalent cancer in men and consists of both indolent and aggressive phenotypes. While active surveillance is recommended for the former, current treatments for the latter include surgery, radiation, chemo and hormonal therapy. It has been observed that the recurrence in the tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bordoloi, Devivasha, Xiao, Peng, Choi, Hyeree, Ho, Michelle, Perales-Puchalt, Alfredo, Khoshnejad, Makan, Kim, J. Joseph, Humeau, Laurent, Srinivasan, Alagarsamy, Weiner, David B., Muthumani, Kar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045963/ https://www.ncbi.nlm.nih.gov/pubmed/33884106 http://dx.doi.org/10.18632/genesandcancer.214

Ejemplares similares

Synthetic DNA Delivery of an Engineered Arginase Enzyme Can Modulate Specific Immunity In Vivo
por: Khoshnejad, Makan, et al.
Publicado: (2020)

Development of Siglec-9 Blocking Antibody to Enhance Anti-Tumor Immunity
por: Choi, Hyeree, et al.
Publicado: (2021)

Neutralization of hepatitis B virus by a novel DNA-encoded monoclonal antibody
por: Zankharia, Urvi S., et al.
Publicado: (2020)

Landscape of humoral immune responses against SARS-CoV-2 in patients with COVID-19 disease and the value of antibody testing
por: Mahalingam, Sundarasamy, et al.
Publicado: (2021)

Simplifying checkpoint inhibitor delivery through in vivo generation of synthetic DNA-encoded monoclonal antibodies (DMAbs)
por: Perales-Puchalt, Alfredo, et al.
Publicado: (2019)

Synthetic DNA delivery by electroporation promotes robust in vivo sulfation of broadly neutralizing anti-HIV immunoadhesin eCD4-Ig
por: Xu, Ziyang, et al.
Publicado: (2018)

Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibody
por: Muthumani, Kar, et al.
Publicado: (2017)

Development of Novel DNA-Encoded PCSK9 Monoclonal Antibodies as Lipid-Lowering Therapeutics
por: Khoshnejad, Makan, et al.
Publicado: (2019)

A novel synthetic DNA vaccine elicits protective immune responses against Powassan virus
por: Choi, Hyeree, et al.
Publicado: (2020)

Novel Synthetic DNA Immunogens Targeting Latent Expressed Antigens of Epstein–Barr Virus Elicit Potent Cellular Responses and Inhibit Tumor Growth
por: Wojtak, Krzysztof, et al.
Publicado: (2019)

A mAb against surface-expressed FSHR engineered to engage adaptive immunity for ovarian cancer immunotherapy
por: Bordoloi, Devivasha, et al.
Publicado: (2022)

DNA immunotherapy targeting BARF1 induces potent anti-tumor responses against Epstein-Barr-virus-associated carcinomas
por: Zhu, Xizhou, et al.
Publicado: (2021)

Designed DNA-Encoded IL-36 Gamma Acts as a Potent Molecular Adjuvant Enhancing Zika Synthetic DNA Vaccine-Induced Immunity and Protection in a Lethal Challenge Model
por: Louis, Lumena, et al.
Publicado: (2019)

Identification of Novel Neutralizing Monoclonal Antibodies against SARS-CoV-2 Spike Glycoprotein
por: Bordoloi, Devivasha, et al.
Publicado: (2021)

In Vivo Assembly of Nanoparticles Achieved through Synergy of Structure‐Based Protein Engineering and Synthetic DNA Generates Enhanced Adaptive Immunity
por: Xu, Ziyang, et al.
Publicado: (2020)

Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy
por: Flingai, Seleeke, et al.
Publicado: (2015)

Nanoparticle Vaccines: In Vivo Assembly of Nanoparticles Achieved through Synergy of Structure‐Based Protein Engineering and Synthetic DNA Generates Enhanced Adaptive Immunity (Adv. Sci. 8/2020)
por: Xu, Ziyang, et al.
Publicado: (2020)

Multivalent in vivo delivery of DNA-encoded bispecific T cell engagers effectively controls heterogeneous GBM tumors and mitigates immune escape
por: Park, Daniel H., et al.
Publicado: (2023)

Preexisting vs. de novo antibodies against SARS-CoV-2 in individuals without or with virus infection: impact on antibody therapy, vaccine research and serological testing
por: Muthumani, Kar, et al.
Publicado: (2021)

Siglec-7 glyco-immune binding mAbs or NK cell engager biologics induce potent antitumor immunity against ovarian cancers
por: Bordoloi, Devivasha, et al.
Publicado: (2023)

IL-33 delays metastatic peritoneal cancer progression inducing an allergic microenvironment
por: Perales-Puchalt, Alfredo, et al.
Publicado: (2018)

Protective immunity by an engineered DNA vaccine for Mayaro virus
por: Choi, Hyeree, et al.
Publicado: (2019)

Synthetic DNA Vaccines: Improved Vaccine Potency by Electroporation and Co-Delivered Genetic Adjuvants
por: Flingai, Seleeke, et al.
Publicado: (2013)

Expanding the Reach of Monoclonal Antibodies: A Review of Synthetic Nucleic Acid Delivery in Immunotherapy
por: Chung, Christopher, et al.
Publicado: (2023)

A synDNA vaccine delivering neoAg collections controls heterogenous, multifocal murine lung and ovarian tumors via robust T cell generation
por: Bhojnagarwala, Pratik S., et al.
Publicado: (2021)

Active immunoprophylaxis with a synthetic DNA-encoded monoclonal anti-respiratory syncytial virus scFv-Fc fusion protein confers protection against infection and durable activity
por: Schultheis, Katherine, et al.
Publicado: (2020)

Active Immunoprophylaxis and Vaccine Augmentations Mediated by a Novel Plasmid DNA Formulation
por: Schommer, Nina N., et al.
Publicado: (2019)

Rapid response to an emerging infectious disease – Lessons learned from development of a synthetic DNA vaccine targeting Zika virus
por: Kudchodkar, Sagar B., et al.
Publicado: (2018)

Synthetic nucleic acid antibody prophylaxis confers rapid and durable protective immunity against Zika virus challenge
por: Choi, Hyeree, et al.
Publicado: (2019)

Editorial: Identification of therapeutic targets and novel biomarkers in prostate cancer volume II
por: Sharad, Shashwat, et al.
Publicado: (2023)

Harnessing Recent Advances in Synthetic DNA and Electroporation Technologies for Rapid Vaccine Development Against COVID-19 and Other Emerging Infectious Diseases
por: Xu, Ziyang, et al.
Publicado: (2020)

CuidaTXT: A Text Message Dementia-Caregiver Intervention for Latinos
por: Puchalt, Jaime Perales
Publicado: (2020)

DEVELOPING AND TESTING THE FEASIBILITY OF A TEXT MESSAGE DEMENTIA CAREGIVER SUPPORT INTERVENTION FOR LATINOS
por: Puchalt, Jaime Perales
Publicado: (2022)

DMAb inoculation of synthetic cross reactive antibodies protects against lethal influenza A and B infections
por: Elliott, Sarah T. C., et al.
Publicado: (2017)

Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2
por: Saini, Pratima, et al.
Publicado: (2023)

Intradermal delivery of a synthetic DNA vaccine protects macaques from Middle East respiratory syndrome coronavirus
por: Patel, Ami, et al.
Publicado: (2021)

Peptide-Based Subunit Vaccine against Hookworm Infection
por: Skwarczynski, Mariusz, et al.
Publicado: (2012)

In vivo DNA-launched bispecific T cell engager targeting IL-13Rα2 controls tumor growth in an animal model of glioblastoma multiforme
por: Bhojnagarwala, Pratik S., et al.
Publicado: (2022)

Tumor-Associated Antigens for Specific Immunotherapy of Prostate Cancer
por: Kiessling, Andrea, et al.
Publicado: (2012)

Multivalent DNA Vaccines as a Strategy to Combat Multiple Concurrent Epidemics: Mosquito-Borne and Hemorrhagic Fever Viruses
por: Jiang, Jingjing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i2rmkbhd6obfdbaeoh1k9ot0cg